{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:05:39Z","timestamp":1761663939170,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.anpedi.2020.04.028","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T17:22:57Z","timestamp":1594056177000},"page":"253-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disopiramida como tratamiento coadyuvante en miocardiopat\u00eda hipertr\u00f3fica obstructiva"],"prefix":"10.1016","volume":"94","author":[{"given":"Mois\u00e9s","family":"Rodriguez-Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro Antonio","family":"P\u00e9rez-Reviriego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Castellano-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena Mar\u00eda","family":"Cascales-Poyatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2020.04.028_bib0035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/2047487317702519","article-title":"Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis","volume":"24","author":"Norrish","year":"2017","journal-title":"Eur J Prev Cardiolog"},{"key":"10.1016\/j.anpedi.2020.04.028_bib0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1573403X1201160126125403","article-title":"Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice","volume":"12","author":"Sherrid","year":"2016","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.anpedi.2020.04.028_bib0045","first-page":"637","article-title":"Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death Fundamental & Clinical Pharmacology","volume":"24","author":"\u00d6stman-Smith","year":"2010","journal-title":"Blackwell Publishing Ltd;"},{"key":"10.1016\/j.anpedi.2020.04.028_bib0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1017\/S1047951117002384","article-title":"Disopyramide use in infants and children with hypertrophic cardiomyopathy","volume":"28","author":"O\u2019Connor","year":"2018","journal-title":"Cardiology in the Young"},{"key":"10.1016\/j.anpedi.2020.04.028_bib0055","first-page":"209","article-title":"Disopyramide as rescue treatment in a critically ill infant with obstructive hypertrophic cardiomyopathy refractory to beta blockers","volume":"15","author":"Rodriguez-Gonzalez","year":"2017","journal-title":"J Cardiol Cases"},{"key":"10.1016\/j.anpedi.2020.04.028_bib0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1253\/circj.66.709","article-title":"Effective disopyramide treatment in a boy with mid-ventricular hypertrophic obstructive cardiomyopathy","volume":"66","author":"Teraguchi","year":"2002","journal-title":"Circ J"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403320302186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403320302186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:21Z","timestamp":1761663141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403320302186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1695403320302186"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2020.04.028","relation":{},"ISSN":["1695-4033"],"issn-type":[{"type":"print","value":"1695-4033"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disopiramida como tratamiento coadyuvante en miocardiopat\u00eda hipertr\u00f3fica obstructiva","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2020.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}